CONCLUSION
Select molecular mutations in thyroid nodules were associated with
specific Bethesda diagnostic categories on cytology. BRAF V600E
mutations were mostly associated with Bethesda categories V and VI,
whereas RAS and EIF1AX mutations, copy number alterations, and GEP were
related to Bethesda categories III and IV. This information may guide
clinicians in the prediction of molecular mutations of thyroid nodules
and potentially improve management.